Also, the percentage of TAMs within CD11b+ population was significantly higher in C-100-day-30 than either C-225-day-7 or C-100-day-7 (Supplementary Figure 7D), indicating its correlation with the immunosuppressive TME of a full-blown tumor. The gene discussed is ITGAM; the disease is neoplasm.